FMII
EGRX

Farmers & Merchants Investments Inc’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Farmers & Merchants Investments Inc’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-7
Closed -$110 – 1801
2023
Q3 		$110 Hold
7
– – ﹤0.01% 1735
2023
Q2 		$136 Hold
7
– – ﹤0.01% 1742
2023
Q1 		$199 Hold
7
– – ﹤0.01% 1708
2022
Q4 		$205 Hold
7
– – ﹤0.01% 1732
2022
Q3 		$0 Buy
+7
New +$257 ﹤0.01% 1798

Other funds holding EGRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Farmers & Merchants Investments Inc's EGRX Position: Q4 2023 in Review

Farmers & Merchants Investments Inc sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q4 2023, closing a stake of 7 shares — an estimated $110 sold.

Farmers & Merchants Investments Inc first reported a position in EGRX in Q3 2022 and held it in 5 quarters. The position peaked at $205 in Q4 2022. 104 funds tracked by Wall St. Rank hold EGRX as of Q4 2023.

  • Farmers & Merchants Investments Inc reported no remaining Eagle Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
  • Farmers & Merchants Investments Inc sold 7 Eagle Pharmaceuticals, Inc. shares in Q4 2023, an estimated $110.
  • Farmers & Merchants Investments Inc first reported a position in Eagle Pharmaceuticals, Inc. in Q3 2022 and held it in 5 quarters.
  • Farmers & Merchants Investments Inc's Eagle Pharmaceuticals, Inc. position peaked at $205 in Q4 2022.
  • 104 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q4 2023.

Based on Farmers & Merchants Investments Inc's 13F filing for Q4 2023, filed 23 Jan 2024.